Table 2.
| Design | T/t group | Baseline | 1 week | % reduction | 2 weeks | % reduction |
|---|---|---|---|---|---|---|
| Lycopene | OP | 1.60 ± 1.41 | 0.80 ± 0.45* | 50.0 ± 17.02 | 0.40 ± 0.55* | 75.0 ± 15.25# |
| Non-OP | 1.40 ± 1.14 | 0.80 ± 0.84* | 42.86 ± 6.56 | 0.50 ± 0.55* | 56.43 ± 12.94 | |
| Placebo | OP | 1.60 ± 0.89 | 1.20 ± 0.45* | 25.0 ± 12.36 | 0.60 ± 0.55* | 62.5 ± 9.55 |
| Non-OP | 1.20 ± 0.45 | 1.00 ± 0.71* | 16.67 ± 9.16 | 0.89 ± 0.55* | 26.0 ± 18.18 |
* Statistically significant (p < 0.05) within the group.
# Statistically significant relative to NOP-placebo (p < 0.001) and NOP-lycopene (p < 0.05).